Home Cart Sign in  
Chemical Structure| 363600-92-4 Chemical Structure| 363600-92-4

Structure of C29
CAS No.: 363600-92-4

Chemical Structure| 363600-92-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

C29 is a Toll-like receptor 2 (TLR2) inhibitor. C29 blocks hTLR2/1 and hTLR2/6 signaling with IC50 values of 19.7 μM and 37.6 μM, respectively. C29 has anti-inflammatory and immunomodulatory effects and can be used in research on rheumatic diseases and inflammation-related studies.

Synonyms: TLR2-IN-C29

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of C29

CAS No. :363600-92-4
Formula : C16H15NO4
M.W : 285.29
SMILES Code : O=C(O)C1=CC=CC(/N=C/C2=CC=CC(OC)=C2O)=C1C
Synonyms :
TLR2-IN-C29
MDL No. :MFCD01248566
InChI Key :WTGMGRFVBFDHGQ-UHFFFAOYSA-N
Pubchem ID :3579893

Safety of C29

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of C29

pyroptosis
TLR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
786-O cells 2.5 µM 24 h To evaluate the stability of C29 in cells, results showed that C29 is highly stable in cells Theranostics. 2019 Jul 9;9(18):5332-5346.
HuVEC cells 2.5 µM 1 h To evaluate the effect of C29 on CXCR1 or CXCR2 levels at the plasma membrane of HuVEC cells stimulated with CXCL7 or CXCL8, results showed that C29 prevented CXCL7/8-dependent internalization of their receptors Theranostics. 2019 Jul 9;9(18):5332-5346.
HepG2 cells different doses To evaluate the effect of C29 on the mRNA levels of ESRRα, ApoB, MTTP, and PLA2G12B in HepG2 cells, results showed that C29 dose-dependently suppressed the expression of these genes. Theranostics. 2020 Aug 29;10(24):10874-10891.
BV-2 microglial cells 100 µM 60 min C29, as a TLR2 inhibitor, was used to study the effects of P. gingivalis-LPS and E. coli-LPS on the immuno-inflammatory response in BV-2 microglial cells. The results showed that C29 could reverse the LPS-induced upregulation of TLR2 and inflammatory factors. Front Cell Infect Microbiol. 2021 Mar 18;11:606986.
RAW 264.7 murine macrophages 100 μM 1 h Inhibited the TLR2/MyD88/NF-κB signaling pathway, reducing M1 macrophage polarization and cytokine production EBioMedicine. 2024 Oct;108:105340.
LS174T cells 50 µM 6 h C29 significantly abolished the induction of TFF3 by EcN EVs and prevented the downregulation of miR7-5p Nutrients. 2023 May 24;15(11):2437.
THP1 cells 150 µM 1 h Inhibited TLR2, blocking S2 protein-induced inflammatory response Elife. 2021 Dec 6;10:e68563.
Calu3 cells 150 µM 1 h Inhibited TLR2, blocking S2 protein-induced inflammatory response Elife. 2021 Dec 6;10:e68563.
BV-2 cells 100 μM 4, 12, 24 h C29 significantly blocked the upregulation of COX-2 protein levels caused by LTA treatment. J Cell Mol Med. 2024 Dec;28(23):e70247.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.51mL

0.70mL

0.35mL

17.53mL

3.51mL

1.75mL

35.05mL

7.01mL

3.51mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories